Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised co

来源 :2015全国糖尿病足综合治疗、北京手足修复与重建学术研讨会 | 被引量 : 0次 | 上传用户:xiaobu000
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background Diabetic foot wounds, particularly those secondary to amputation, are very complex and difficult to treat.We investigated whether negative pressure wound therapy (NPWT) improves the proportion and rate of wound healing after partial foot amputation in patients with diabetes.Methods We enrolled 162 patients into a 16-week, 18-centre, randomised clinical trial in the USA.Inclusion criteria consisted of partial foot amputation wounds up to the transmetatarsal level and evidence of adequate perfusion.Patients who were randomly assigned to NPWT (n=77) received treatment with dressing changes every 48 h.Control patients (n=85) received standard moist wound care according to consensus guidelines.NPWT was delivered through the Vacuum Assisted Closure (VAC) Therapy System.Wounds were treated until healing or completion of the 112-day period of active treatment.Analysis was by intention to treat.This study has been registered with ClinicalTrials.gov, number NCT00224796.Findings More patients healed in the NPWT group than in the control group (43 [56%] vs 33 [39%], p=0.040).The rate of wound healing, based on the time to complete closure, was faster in the NPWT group than in controls (p=0.005).The rate of granulation tissue formation, based on the time to 76-100% formation in the wound bed, was faster in the NPWT group than in controls (p=0.002).The frequency and severity of adverse events (of which the most common was wound infection) were similar in both treatment groups.Interpretation NPWT delivered by the VAC Therapy System seems to be a safe and effective treatment for complex diabetic foot wounds, and could lead to a higher proportion of healed wounds, faster healing rates, and potentially fewer re-amputations than standard care.
其他文献
目的:观察奥沙利铂联合替吉奥治疗晚期食管癌的临床疗效.方法;5例TNM分期为Ⅲ-Ⅳ期晚期食管癌患者,可评价疗效及毒副反应24例,奥沙利铂130mg/m2,静脉滴注dl,替吉奥胶囊80mg/m2/天,分2次口服,连服14天,停药7天,21天为1个周期.每例至少治疗2个周期后评价疗效.结果;24例患者中,平均每例患者治疗3.5周期,完全缓解(CR)为0例,部分缓解(PR)为12例,疾病稳定(SD)7,
会议
目的:探讨护理干预对经皮穿刺微波消融(PMAT)肺癌患者疾病不确定感的影响.方法:将100例微波消融治疗肺癌患者随机分为常规组(50例)和干预组(50例),分别在入院、术前、术后给予常规健康教育模式和护理干预有效沟通模式.分别比较入院时、出院时疾病不确定感评分.出院时评价患者生活质量.结果:两组患者疾病不确定感评分出院时均较入院时降低(P<0.01),且干预组明显低于常规组(P<0.01).干预组
会议
目的:探讨肝门部胆管癌的治疗方法和临床效果.方法:回顾性分析我院2006年1月2014年12月收治的85例肝门部胆管癌的临床资料.结果:78例获随访,平均随访时间为24个月(2个月~5.5年).手术切除28例,中位生存时间为20个月,1、3、5年生存率分别为71.4%、28.6%、3.6%;手术引流31例,中位生存时间为11个月,1年生存率为29.0%,无3年生存者,手术切除组优于手术引流组(P<
会议
近年来,伊立替康在抗肿瘤疾病的过程中疗效显著,迟发性腹泻是其剂量限制性毒性,对患者化疗方案的进行及其生活质量存在着严重影响。因此,在临床中如何有效防治延迟性腹泻的发生有着重要意义。
会议
目的:评估荧光原位杂交(FISH)技术在检测胃癌标本中HER2基因扩增的应用价值.方法:分别采用免疫组织化学(IHC)和FISH两种方法,检测325例胃癌中HER2蛋白表达及HER2基因扩增的情况.结果:325例胃癌IHC检测结果显示HER(3+)25例,阳性率为7.69%,HER2 (2+) 31例(9.54%),HER2 (1+) 61例(18.77%),HER2(0)208例(64.0%).
会议
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is known for its ability to selectively induce apoptosis in malignant cells.However, human hepatocellular carcinoma (HCC) cells di
会议
Background: Gastric cancer is the fourth most common malignant cancer and is the second leading cause of cancer death worldwide.We evaluated the association of the immunohistochemical RTN4 expression
会议
G蛋白信号调节蛋白(RGS)是能够直接与激活的Gα亚基结合,负性调节G蛋白信号的一组多功能蛋白家族.在肿瘤领域,RGS5作为RGS家族一员,在多种肿瘤组织的血管周细胞中有高表达,在肿瘤形成过程中对血管的成熟和重构发挥着重要作用.RGS5基因的缺失可使肿瘤血管正常化并改善肿瘤血供,既可促进自体免疫细胞进入肿瘤也有利于改善乏氧增加放化疗敏感性.这可能为我们提供了肿瘤治疗的新靶点.
会议
目的 调查放射治疗记录单填写现状,探讨其对放疗流程和患者满意度的影响.方法 2014年5月-7月我院放疗中心放疗患者为调查对象,调查放射治疗记录单的完成情况,统计放射治疗记录单空项数目.并将放射治疗记录单划分为优秀、合格和不合格三个等级,三个等级对患者放疗实施的顺利度和患者满意度均带来不同的结果.并分析造成不合格的原因.结果 通过对429例适形调强放疗患者记录单的统计,其中95例为优秀,203例合
会议
目的:观察膝下动脉腔内成形术治疗重症糖尿病肢体血管病变的近期疗效,初步评估其临床价值.方法:29例重症糖尿病肢体血管病变患者采用INVATEC-DEEP球囊进行膝下动脉腔内成形,观察治疗前后的症状、体征、踝肱指数(ABI)、肢端的经皮氧分压(TcP02)并进行随访.结果:29例患者(共29条肢体),术后即刻影像学成功率62.1%.全部随访6个月,手术未成功的患者6个月存活率88.9%,肢体存活率8